Prospective Observational Post-marketing Study of Tafluprost 0.0015%/Timolol 0.5% Combination Ophthalmic Solution for Glaucoma and Ocular Hypertension: Short-Term Efficacy and Safety

Category Primary study
JournalOphthalmology and Therapy
Year 2016
This article has no abstract
Epistemonikos ID: ec324e4fc503701e17dc8e2dd579d34389aed1c8
First added on: Feb 08, 2025